3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Classical hematology
1
Conditions
Venous Thromboembolism
5
Venous Thrombosis
4
Neoplasms
4
Pulmonary Embolism
3
Thrombosis
1
Thromboembolism
1
Pancreatic Neoplasms
1
Obesity
1
Multiple Myeloma
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Interventions
indole-3-carbinol
1
Vitamin D
1
Tablets
1
Observation
1
Nutrition Assessment
1
Methods
1
Metformin
1
Megestrol Acetate
1
Magnesium
1
Educational Status
1
Early Intervention, Educational
1
Docosahexaenoic Acids
1
Dalteparin
1
Cooking
1
Cholecalciferol
1
Blood Specimen Collection
1
Adrenalectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Obesity
×
Dalteparin
×
Clear all
NCT03297359
2024-01-23
WAVe
Ottawa Hospital Research Institute
Phase 2
Terminated
92 enrolled